Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Imatron CT Scanner Picked For NIH Cardiovascular Disease Screening Study

This article was originally published in The Gray Sheet

Executive Summary

Imatron says the selection of its Ultrafast electron beam computed tomography (EBCT) scanner by the National Heart, Lung and Blood Institute for an upcoming screening study cements the scanner's position as the "gold standard" for assessment of baseline cardiac risk.

You may also be interested in...

ACC/AHA EBT Findings Based On Inappropriate Comparison - Imatron, SAI

Imatron Inc. is critical of research methods the American College of Cardiology and the American Heart Association used to compile an expert consensus document concluding that electron beam computed tomography demonstrates roughly 70% accuracy in predicting cardiac conditions in symptomatic patients.

TTS Pharma Wants To Bring First Legal CBD Oil To The UK

TTS Pharma CEO Mark Tucker discusses his ambition to bring a legal CBD oil to the UK market, following the recent submission of a European Union novel food application.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts